ArticleNutrition & metabolism2026
Purple sweet potato (Ipomoea batatas L. Lam) leaves extract prevents weight gain and lipotoxicity in mice fed a high-fat diet by increasing metabolic flexibility and oxidative metabolism in skeletal muscle and brown adipose tissue.
Article in Nutrition & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPurple sweet potato leaves are a rich source of caffeoylquinic acids (CQA) and related compounds with potential metabolic benefits. Our previous research demonstrated that 5-CQA and 3,4-diCQA increase mitochondrial respiration in primary hepatocytes. To explore the translational relevance of purple sweet potato leaves extract (PSPLE) in the management and treatment of obesity, we evaluated the effect of PSPLE in C57BL/6 mice fed a high-fat (HF) diet supplemented with either 1% or 3% PSPLE (w/w) and assessed insulin secretion in INS-1E cells.
methodsPSPLE phenolic compounds were identified by LC-MS. Male C57BL/6J mice were fed (1) a Control, (2) high-fat (HF) diet, (3) HF diet supplemented with 1% and (4) HF diet supplemented with 3% of PSPLE for 15 weeks. Body composition, energy expenditure, glucose and insulin tolerance, serum metabolites, and tissue morphology were evaluated. AMPK activation was analyzed in the liver and skeletal muscle. Complementary, β-cell function was assessed in vitro.
resultsLC-MS revealed that PSPLE contained abundant CQA derivatives (5-CQA, caffeic acid, 3,4-di-CQA, 3,5-di-CQA, 4,5-di-CQA, 4 F-5CQA, and 3,4,5-tri-CQA). The HF + 1% PSPLE diet attenuated weight gain and adipocyte hypertrophy, increased brown adipose UCP-1 expression, and prevented hepatic steatosis. AMPK phosphorylation was enhanced in the liver and muscle, paralleling higher oxygen consumption and energy expenditure. Although PSPLE stimulated β-cell metabolism and insulin secretion in vitro, in vivo glucose tolerance showed only modest improvement, likely reflecting the multiple regulatory inputs on insulin secretion under physiological conditions.
conclusionsPSPLE enhanced metabolic flexibility and oxidative capacity in HF-fed mice by activating AMPK-dependent pathways in muscle, liver, and adipose tissue. The higher efficacy of the 1% PSPLE indicates a hormetic response, where low polyphenol exposure triggers adaptive mitochondrial and metabolic activation, on the contrary, higher doses offer no further benefits. These results present PSPLE as a sustainable, polyphenol-rich food ingredient with potential to combat obesity-related metabolic dysfunction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.